{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T22:25:41Z","timestamp":1787955941801,"version":"build-2784847793"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T00:00:00Z","timestamp":1551744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol Suppl"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s11789-019-00101-8","type":"journal-article","created":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T20:28:52Z","timestamp":1551817732000},"page":"28-32","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Is lipoprotein(a) a\u00a0risk factor for ischemic stroke and venous thromboembolism?"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0101-4557","authenticated-orcid":false,"given":"Alexander Heinrich","family":"Nave","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold","family":"von Eckardstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,5]]},"reference":[{"key":"101_CR1","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1093\/eurheartj\/ehx033","volume":"38","author":"B Gencer","year":"2017","unstructured":"Gencer B, Kronenberg F, Stroes ES, Mach F (2017) Lipoprotein(a): the revenant. Eur Heart\u00a0J 38:1553\u20131560. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehx033","journal-title":"Eur Heart J"},{"key":"101_CR2","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1194\/jlr.R067314","volume":"57","author":"K Schmidt","year":"2016","unstructured":"Schmidt K, Noureen A, Kronenberg F, Utermann G (2016) Structure, function, and genetics of lipoprotein (a). J\u00a0Lipid Res 57:1339\u20131359. \n                    https:\/\/doi.org\/10.1194\/jlr.R067314","journal-title":"J Lipid Res"},{"key":"101_CR3","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1194\/jlr.R060582","volume":"57","author":"MB Boffa","year":"2016","unstructured":"Boffa MB, Koschinsky ML (2016) Lipoprotein (a): truly a\u00a0direct prothrombotic factor in cardiovascular disease? J\u00a0Lipid Res 57:745\u2013757. \n                    https:\/\/doi.org\/10.1194\/jlr.R060582","journal-title":"J Lipid Res"},{"key":"101_CR4","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1161\/STR.0b013e318296aeca","volume":"44","author":"RL Sacco","year":"2013","unstructured":"Sacco RL, Kasner SE, Broderick JP et\u00a0al (2013) An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American heart association\/American stroke association. Stroke 44:2064\u20132089. \n                    https:\/\/doi.org\/10.1161\/STR.0b013e318296aeca","journal-title":"Stroke"},{"key":"101_CR5","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1161\/CIRCRESAHA.116.308413","volume":"120","author":"VL Feigin","year":"2017","unstructured":"Feigin VL, Norrving B, Mensah GA (2017) Global burden of stroke. Circ Res 120:439\u2013448. \n                    https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.308413","journal-title":"Circ Res"},{"key":"101_CR6","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1056\/NEJMoa1802712","volume":"378","author":"P Amarenco","year":"2018","unstructured":"Amarenco P, Lavall\u00e9e PC, Monteiro Tavares L et al (2018) Five-year risk of stroke after TIA or minor Ischemic stroke. N\u00a0Engl J Med 378:2182\u20132190. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1802712","journal-title":"N Engl J Med"},{"key":"101_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","volume":"24","author":"HP Adams","year":"1993","unstructured":"Adams HP, Bendixen BH, Jaap Kappelle L et\u00a0al (1993) Classification of subtype of acute Ischemic stroke definitions for use in a\u00a0multicenter clinical trial. Stroke 24:35\u201341","journal-title":"Stroke"},{"key":"101_CR8","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S1474-4422(15)00132-5","volume":"14","author":"L Li","year":"2015","unstructured":"Li L, Yiin GS, Geraghty OC et al (2015) Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: A population-based study. Lancet Neurol 14:903\u2013913. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(15)00132-5","journal-title":"Lancet Neurol"},{"key":"101_CR9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0021-9150(85)90065-6","volume":"58","author":"P K\u00f6ltringer","year":"1985","unstructured":"K\u00f6ltringer P, J\u00fcrgens G (1985) A dominant role of lipoprotein(a) in the investigation and evaluation of parameters indicating the development of cervical atherosclerosis. Atherosclerosis 58:187\u2013198. \n                    https:\/\/doi.org\/10.1016\/0021-9150(85)90065-6","journal-title":"Atherosclerosis"},{"key":"101_CR10","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1161\/01.STR.17.5.942","volume":"17","author":"G Zenker","year":"1986","unstructured":"Zenker G, K\u00f6ltringer P, Bon\u00e9 G et\u00a0al (1986) Lipoprotein(a) as a\u00a0strong indicator for cerebrovascular disease. Stroke 17:942\u2013945. \n                    https:\/\/doi.org\/10.1161\/01.STR.17.5.942","journal-title":"Stroke"},{"key":"101_CR11","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1001\/jama.1995.03520400039041","volume":"273","author":"PM Ridker","year":"1995","unstructured":"Ridker PM, Stampfer MJ, Hennekens CH (1995) Plasma concentration of lipoprotein(a) and the risk of future stroke. JAMA 273:1269\u20131273","journal-title":"JAMA"},{"key":"101_CR12","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1001\/jama.296.11.1363","volume":"296","author":"SJ Danik","year":"2006","unstructured":"Danik SJ, Rifai N, Buring JE, Ridker PM (2006) Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women. JAMA 296:1363\u20131370. \n                    https:\/\/doi.org\/10.1001\/jama.296.11.1363","journal-title":"JAMA"},{"key":"101_CR13","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1161\/ATVBAHA.112.255521","volume":"32","author":"D Gurdasani","year":"2012","unstructured":"Gurdasani D, Sjouke B, Tsimikas S et al (2012) Lipoprotein(a) and risk of coronary, cerebrovascular, and peripheral artery disease: the EPIC-Norfolk prospective population study. Arterioscler Thromb Vasc Biol 32:3058\u20133065. \n                    https:\/\/doi.org\/10.1161\/ATVBAHA.112.255521","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"101_CR14","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1161\/STROKEAHA.106.480657","volume":"38","author":"B Smolders","year":"2007","unstructured":"Smolders B, Lemmens R, Thijs V (2007) Lipoprotein (a) and stroke: a\u00a0meta-analysis of observational studies. Stroke 38:1959\u20131966. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.106.480657","journal-title":"Stroke"},{"key":"101_CR15","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1001\/jama.2009.1063","volume":"302","author":"S Erqou","year":"2009","unstructured":"Erqou S, Kaptoge S, Perry P et\u00a0al (2009) Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA 302:412\u2013423","journal-title":"JAMA"},{"key":"101_CR16","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.atherosclerosis.2015.08.021","volume":"242","author":"AHAH Nave","year":"2015","unstructured":"Nave AHAH, Lange KSKS, Leonards COCO et al (2015) Lipoprotein (a) as a\u00a0risk factor for ischemic stroke: a meta-analysis. Atherosclerosis 242:496\u2013503. \n                    https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.08.021","journal-title":"Atherosclerosis"},{"key":"101_CR17","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/S0140-6736(02)11520-0","volume":"360","author":"R Str\u00e4ter","year":"2002","unstructured":"Str\u00e4ter R, Becker S, von Eckardstein A et al (2002) Prospective assessment of risk factors for recurrent stroke during childhood\u2014a 5\u2011year follow-up study. Lancet 360:1540\u20131545. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(02)11520-0","journal-title":"Lancet"},{"key":"101_CR18","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1161\/01.STR.0000239694.19359.88","volume":"37","author":"T Ohira","year":"2006","unstructured":"Ohira T, Shahar E, Chambless LE et\u00a0al (2006) Risk factors for ischemic stroke subtypes: the atherosclerosis risk in communities study. Stroke 37:2493\u20132498. \n                    https:\/\/doi.org\/10.1161\/01.STR.0000239694.19359.88","journal-title":"Stroke"},{"key":"101_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/JAHA.117.007372","volume":"6","author":"KN Aronis","year":"2017","unstructured":"Aronis KN, Di Zhao, Hoogeveen RC et\u00a0al (2017) Associations of Lipoprotein(a) levels with incident atrial fibrillation and Ischemic Stroke: the ARIC (Atherosclerosis Risk in Communities) study. J\u00a0Am Heart Assoc 6:1\u201311. \n                    https:\/\/doi.org\/10.1161\/JAHA.117.007372","journal-title":"J Am Heart Assoc"},{"key":"101_CR20","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.atherosclerosis.2010.07.007","volume":"212","author":"BS Kim","year":"2010","unstructured":"Kim BS, Jung HS, Bang OY et\u00a0al (2010) Elevated serum lipoprotein(a) as a\u00a0potential predictor for combined intracranial and extracranial artery stenosis in patients with ischemic stroke. Atherosclerosis 212:682\u2013688. \n                    https:\/\/doi.org\/10.1016\/j.atherosclerosis.2010.07.007","journal-title":"Atherosclerosis"},{"key":"101_CR21","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1161\/STROKEAHA.116.014436","volume":"48","author":"KS Lange","year":"2017","unstructured":"Lange KS, Nave AH, Liman TG et\u00a0al (2017) Lipoprotein(a) levels and recurrent vascular events after first Ischemic stroke. Stroke 48:36\u201342. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.116.014436","journal-title":"Stroke"},{"key":"101_CR22","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1007\/s12035-016-0346-9","volume":"55","author":"X-W Hong","year":"2018","unstructured":"Hong X\u2011W, Wu D\u2011M, Lu J et al (2018) Lipoprotein (a) as a\u00a0predictor of early stroke recurrence in acute Ischemic stroke. Mol Neurobiol 55:718\u2013726. \n                    https:\/\/doi.org\/10.1007\/s12035-016-0346-9","journal-title":"Mol Neurobiol"},{"key":"101_CR23","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1055\/s-0036-1598002","volume":"43","author":"F Dentali","year":"2017","unstructured":"Dentali F, Gessi V, Marcucci R et al (2017) Lipoprotein(a) as a\u00a0risk factor for venous thromboembolism: a systematic review and meta-analysis of the literature. Semin Thromb Hemost 43:614\u2013620. \n                    https:\/\/doi.org\/10.1055\/s-0036-1598002","journal-title":"Semin Thromb Hemost"},{"key":"101_CR24","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.wneu.2015.10.059","volume":"87","author":"C-W Wang","year":"2016","unstructured":"Wang C\u2011W, Su L\u2011L, Tao S\u2011B et al (2016) An increased serum level of lipoprotein(a) is a\u00a0predictor for deep vein thrombosis in patients with spinal cord injuries. World Neurosurg 87:607\u2013612. \n                    https:\/\/doi.org\/10.1016\/j.wneu.2015.10.059","journal-title":"World Neurosurg"},{"key":"101_CR25","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1161\/ATVBAHA.112.248765","volume":"32","author":"PR Kamstrup","year":"2012","unstructured":"Kamstrup PR, Tybj\u00e6rg-Hansen A, Nordestgaard BG (2012) Genetic evidence that lipoprotein(a) associates with atherosclerotic stenosis rather than venous thrombosis. Arterioscler Thromb Vasc Biol 32:1732\u20131741. \n                    https:\/\/doi.org\/10.1161\/ATVBAHA.112.248765","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"101_CR26","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.thromres.2010.06.007","volume":"126","author":"MA Rodger","year":"2010","unstructured":"Rodger MA, Le Gal G, Carrier M et\u00a0al (2010) Serum lipoprotein (a) levels in patients with first unprovoked venous thromboembolism is not associated with subsequent risk of recurrent VTE. Thromb Res 126:222\u2013226. \n                    https:\/\/doi.org\/10.1016\/j.thromres.2010.06.007","journal-title":"Thromb Res"},{"key":"101_CR27","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.amjmed.2003.06.005","volume":"115","author":"R Marcucci","year":"2003","unstructured":"Marcucci R, Liotta AA, Cellai AP et\u00a0al (2003) Increased plasma levels of lipoprotein(a) and the risk of idiopathic and recurrent venous thromboembolism. Am J Med 115:601\u2013605","journal-title":"Am J Med"},{"key":"101_CR28","doi-asserted-by":"publisher","first-page":"e0149427","DOI":"10.1371\/journal.pone.0149427","volume":"11","author":"E Sticchi","year":"2016","unstructured":"Sticchi E, Magi A, Kamstrup PR et al (2016) Apolipoprotein(a) Kringle-IV type 2 copy number variation is associated with venous thromboembolism. PLoS ONE 11:e149427. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0149427","journal-title":"PLoS ONE"},{"key":"101_CR29","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1161\/CIRCULATIONAHA.108.789008","volume":"118","author":"G Young","year":"2008","unstructured":"Young G, Albisetti M, Bonduel M et\u00a0al (2008) Impact of inherited thrombophilia on venous thromboembolism in children. Circulation 118:1373\u20131382. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.789008","journal-title":"Circulation"},{"key":"101_CR30","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/01.CIR.100.7.743","volume":"100","author":"U Nowak-G\u00f6ttl","year":"1999","unstructured":"Nowak-G\u00f6ttl U, Junker R, Hartmeier M et al (1999) Increased lipoprotein(a) is an important risk factor for venous thromboembolism in childhood. Circulation 100:743\u2013748. \n                    https:\/\/doi.org\/10.1016\/s0140-6736(05)80081-9","journal-title":"Circulation"},{"key":"101_CR31","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1161\/01.CIR.0000087598.05977.45","volume":"108","author":"C Heller","year":"2003","unstructured":"Heller C, Heinecke A, Junker R et\u00a0al (2003) Cerebral venous thrombosis in children: A multifactorial origin. Circulation 108:1362\u20131367. \n                    https:\/\/doi.org\/10.1161\/01.CIR.0000087598.05977.45","journal-title":"Circulation"},{"key":"101_CR32","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1182\/blood.V97.4.858","volume":"97","author":"U Nowak-G\u00f6ttl","year":"2001","unstructured":"Nowak-G\u00f6ttl U, Junker R, Kreuz W et al (2001) Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors. Blood 97:858\u2013862. \n                    https:\/\/doi.org\/10.1182\/blood.V97.4.858","journal-title":"Blood"},{"key":"101_CR33","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1161\/STROKEAHA.115.011164","volume":"46","author":"S Yaghi","year":"2015","unstructured":"Yaghi S, Elkind MSV (2015) Lipids and Cerebrovascular Disease. Stroke 46:3322\u20133328. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.115.011164","journal-title":"Stroke"}],"container-title":["Clinical Research in Cardiology Supplements"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11789-019-00101-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11789-019-00101-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11789-019-00101-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T19:15:18Z","timestamp":1583262918000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11789-019-00101-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,5]]},"references-count":33,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["101"],"URL":"https:\/\/doi.org\/10.1007\/s11789-019-00101-8","relation":{},"ISSN":["1861-0706","1861-0714"],"issn-type":[{"value":"1861-0706","type":"print"},{"value":"1861-0714","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,5]]},"assertion":[{"value":"5 March 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.H.\u00a0Nave and A.\u00a0von Eckardstein declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}